Related Experiment Videos
Towards a european network for multiple sclerosis trials (ENMST)
L Kappos1, C Polman, A J Thompson
1Outpatient Clinic Neurology-Neurosurgery, University Hospitals, Basel, Switzerland. lkappos@uhbs.ch
Multiple Sclerosis (Houndmills, Basingstoke, England)
|December 11, 2003
Summary
Establishing a European network for multiple sclerosis (MS) treatment trials will improve drug discovery and standardize research. This collaborative approach aims to overcome rising costs and complexity in clinical studies for MS.
Area of Science:
- Neurology
- Clinical Trials
- Pharmaceutical Research
Background:
- Clinical studies for multiple sclerosis (MS) have improved quality but face escalating costs and complexity.
- Industry-independent MS trials are becoming increasingly challenging to conduct.
- There is a need for enhanced collaboration in MS research across Europe.
Purpose of the Study:
- To propose the establishment of a European network for MS treatment trials.
- To facilitate the identification of novel therapeutic agents for MS.
- To standardize protocols and data collection for comparative MS research.
Main Methods:
- A stepwise recruitment of active European centers agreeing to common scientific standards and quality requirements.
- Developing protocols for investigator-industry interactions.
- Identifying common data standards for MS trials.
Main Results:
- The proposed network aims to streamline the identification of effective MS treatments.
- Standardized protocols will enable more robust comparisons between clinical trials.
- Collaboration with existing international organizations and initiatives is planned.
Conclusions:
- A European network can address the challenges of cost and complexity in MS clinical trials.
- Standardization of scientific quality and data is crucial for advancing MS research.
- International collaboration will enhance the global impact of MS treatment development.